Anacor Pharmaceuticals Announces Fourth Quarter and yr End 2011 Financial ... MarketWatch (press release) Anacor is also developing AN2718 as a topical agent product candidate for the treatment of onychomycosis and skin fungal infections and AN2898, a second medicine PDE-4 inhibitor for the treatment of psoriasis and atopic dermatitis. and more » Link To Article
No comments:
Post a Comment